Non ci sono recensioni
This book, now in its third edition, examines the current treatment options for first-line, relapsed, and refractory Hodgkin lymphoma and the appropriate management in special clinical circumstances, including in the elderly, pregnant women, and those with nodular lymphocyte-predominant disease (NLPHL). Careful attention is devoted to the emerging individually tailored treatment strategies, including checkpoint inhibition, that are especially appealing given their potential to reduce early and late treatment side effects in this generally young patient population. In addition, clear guidance is provided on the management of Hodgkin survivors. Other topics addressed include epidemiology, pathogenesis, the role of the microenvironment, initial clinical evaluation, imaging diagnosis, use of staging systems, and prognostic factors. The new edition of Hodgkin Lymphoma: A Comprehensive Overview has been revised and updated by key opinion leaders to reflect recent progress in the field. It will be of great value to hematologists, oncologists, and all others with an interest in Hodgkin lymphoma.
Epidemiology of Hodgkin Lymphoma
Pages 3-23
Hjalgrim, Henrik (et al.)
The Role of Viruses in the Genesis of Hodgkin Lymphoma
Pages 25-45
Jarrett, Ruth F. (et al.)
Pathology and Molecular Pathology of Hodgkin Lymphoma
Pages 47-68
Rosenwald, Andreas (et al.)
Microenvironment, Cross-Talk, and Immune Escape Mechanisms
Pages 69-86
Visser, Lydia (et al.)
What Have We Learnt from Genomics and Transcriptomics in Classic Hodgkin Lymphoma
Pages 87-96
Rossi, Davide (et al.)
Clinical Evaluation
Pages 99-111
Armitage, James O. (et al.)
Functional Imaging in Hodgkin Lymphoma
Pages 113-143
Gallamini, Andrea (et al.)
Prognostic Factors
Pages 145-169
Principles of Radiation Therapy for Hodgkin Lymphoma
Pages 171-197
Yahalom, Joachim (et al.)
Principles of Chemotherapy in Hodgkin Lymphoma
Pages 199-218
Straus, David (et al.)
Treatment of Early Favorable Hodgkin Lymphoma
Pages 219-236
Plattel, Wouter (et al.)
Treatment of Early Unfavorable Hodgkin Lymphoma
Pages 237-247
André, Marc P. E. (et al.)
Treatment of Advanced-Stage Hodgkin Lymphoma
Pages 249-264
Fosså, Alexander (et al.)
Optimizing Decision Making in Hodgkin Lymphoma
Pages 265-273
Parsons, Susan K. (et al.)
Pediatric Hodgkin Lymphoma
Pages 277-296
Hall, Georgina W. (et al.)
The Management of Older Patients with Hodgkin Lymphoma
Pages 297-315
Böll, Boris (et al.)
Nodular Lymphocyte-Predominant Hodgkin Lymphoma
Pages 317-324
Eichenauer, Dennis A. (et al.)
The Management of Hodgkin Lymphoma During Pregnancy
Pages 325-334
Bachanova, Veronika (et al.)
The Management of HIV-Hodgkin Lymphoma
Pages 335-347
Hentrich, Marcus (et al.)
Relapsed and Refractory Hodgkin Lymphoma
Pages 351-363
Tresckow, Bastian (et al.)
Allogeneic Transplantation for Relapsed Hodgkin Lymphoma
Pages 365-380
Sureda, Anna (et al.)
Targeting CD30 in Patients with Hodgkin Lymphoma
Pages 381-393
Kumar, Anita (et al.)
Hodgkin Lymphoma and PD-1 Blockade
Pages 395-409
Merryman, Reid (et al.)
Other New Agents for Hodgkin Lymphoma
Pages 411-416
Moskowitz, Alison J. (et al.)
Quality of Life in Hodgkin Lymphoma
Pages 419-427
Kreissl, Stefanie (et al.)
Second Malignancy Risk After Treatment of Hodgkin Lymphoma
Pages 429-464
Schaapveld, Michael (et al.)
Cardiovascular and Pulmonary Late Effects
Pages 465-483
Aleman, Berthe M. P. (et al.)
Gonadal Dysfunction and Fertility Preservation in Hodgkin Lymphoma Patients
Pages 485-499
Behringer, Karolin (et al.)
Cancer-Related Fatigue in Hodgkin Lymphoma
Pages 501-509
Kreissl, Stefanie (et al.)
Sei sicuro di voler eseguire questa azione?